Difference in response of NK cell activity in newborns and adult to IL-2, IL-12 and IL-15.
The killing activity of cord blood mononuclear cells (cMNC) against cytomegalovirus (CMV)-uninfected and -infected fibroblasts was comparable to that of adult peripheral blood mononuclear cells (aPBMC). The killing activity of cMNC against K562 cells was significantly lower compared with that of aPBMC. Treatment of cMNC and aPBMC with interleukin-2 (IL-2), IL-12 or IL-15 significantly enhanced killing activity against K562 cells and CMV-uninfected and -infected cells. By comparison of cMNC with aPBMC, killing activity against the K562 cells of cMNC was augmented to the level of aPBMC when cultured with IL-2, IL-12 or IL-15. The killing activity of cMNC against CMV-uninfected and -infected fibroblasts did not increase to the level of adult PBMC by treatment with IL-2, IL-12 or IL-15. These data suggest that cord blood contains a functionally different NK cell subpopulation than that among adult NK cells.
Hoshina
T
T
Department of Pediatrics, Mie University School of Medicine, Tsu, Japan.
Kida
K
K
Ito
M
M
D000328:Adult; D019002:CD56 Antigen / Q000276:immunology; D003587:Cytomegalovirus / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D018664:Interleukin-12 / Q000276:immunology* / Q000494:pharmacology; D019409:Interleukin-15 / Q000276:immunology* / Q000494:pharmacology; D007376:Interleukin-2 / Q000276:immunology* / Q000494:pharmacology; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology
D019002:CD56 Antigen; D019409:Interleukin-15; D007376:Interleukin-2; D017452:Receptors, IgG; D018664:Interleukin-12